David A. Wohl

12.0k citations
215 papers · 6.5k · 1 hit paper · h-index 42

Impact in

  • Virology top 0.5%
    • HIV Research and Treatment
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment

Papers in

    • HIV/AIDS Research and Interventions 60
    • HIV/AIDS drug development and treatment 43
    • Viral Infections and Outbreaks Research 16
    • HIV, Drug Use, Sexual Risk 26

David A. Wohl

202 papers receiving 6.3k citations

David A. Wohl's Hit Papers

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus 2021 · 236 citations
2360+1+3Years since publication50100150200

Peers

David A. Wohl
Comparison fields: 5 of 145
  • Virology 1.0k
  • Infectious Diseases 3.1k
  • Emergency Medicine 1.4k
  • Epidemiology 1.3k
  • General Health Professions 698
Replace Ruth M. Greenblatt with:
Ruth M. Greenblatt United States
Mary Young United States
Kathryn Anastos United States
Mardge H. Cohen United States
Praphan Phanuphak Thailand
Pamela Stratton United States
Howard Minkoff United States
Joan S. Chmiel United States
Nancy A. Hessol United States
Rhoda Sperling United States
David A. Wohl relative to Ruth M. Greenblatt United States Ruth M. Greenblatt's profile →
Citations per field
00.5×1.5×
Ruth M. Greenblatt · 1×
Citations per year

Countries citing papers authored by David A. Wohl

Since Specialization
Citations

This map shows the geographic impact of David A. Wohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Wohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Wohl more than expected).

Fields of papers citing papers by David A. Wohl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Wohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Wohl. The network helps show where David A. Wohl may publish in the future.

Co-authors

The 25 scholars most cited alongside David A. Wohl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. Wohl Line = papers co-authored together David A. Wohl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 215 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2012341
2 1997308
3 2017264
4
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
Hit paper breakdown →
2021236
5 2008172
6 2016145
7 2013144
8 2005144
9 2013122
10 2008120
11 2007119
12 2019119
13 2007117
14 2006113
15 2010106
16 200795
17 201490
18 201788
19 200586
20 201184

About David A. Wohl

David A. Wohl is a scholar working on Infectious Diseases, Epidemiology, Emergency Medicine, Virology and Sociology and Political Science, having authored 215 papers that have together received 6.5k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (60 papers), HIV-related health complications and treatments (45 papers), HIV/AIDS drug development and treatment (43 papers), HIV Research and Treatment (34 papers), HIV, Drug Use, Sexual Risk (26 papers), Criminal Justice and Corrections Analysis (25 papers), Viral Infections and Outbreaks Research (16 papers) and Adolescent Sexual and Reproductive Health (14 papers). The work is most often cited by research in Virology (1.0k citations), Infectious Diseases (3.1k citations), Emergency Medicine (1.4k citations), Epidemiology (1.3k citations) and General Health Professions (698 citations). David A. Wohl has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include David L. Rosen, Carol E. Golin, Victor J. Schoenbach, William A. Fischer, Andrew Cheng, Paul E. Sax, Pablo Tebas, Andrew H. Kaplan, Kirsten White and Joel E. Gallant. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Clinical Infectious Diseases, Open Forum Infectious Diseases, AIDS and Behavior and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact